Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Spero Therapeutics, Inc. | Chief Operating Officer | Common Stock | 532K | $718K | $1.35 | Aug 27, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SPRO | Spero Therapeutics, Inc. | Aug 27, 2024 | 1 | -$2.99K | 4 | Aug 29, 2024 | Chief Operating Officer |
SPRO | Spero Therapeutics, Inc. | Feb 1, 2024 | 2 | -$42.1K | 4 | Feb 5, 2024 | Chief Operating Officer |
SPRO | Spero Therapeutics, Inc. | Aug 28, 2023 | 1 | -$2.34K | 4 | Aug 30, 2023 | Chief Development Officer |
SPRO | Spero Therapeutics, Inc. | Feb 1, 2023 | 2 | -$6.31K | 4 | Feb 3, 2023 | Chief Operating Officer |
SPRO | Spero Therapeutics, Inc. | Feb 1, 2022 | 2 | $0 | 4 | Feb 3, 2022 | Chief Development Officer |
SPRO | Spero Therapeutics, Inc. | Aug 26, 2021 | 1 | $0 | 4 | Aug 30, 2021 | Chief Development Officer |